New Test Can Detect Patients’ Risk of Harmful Side Effects from Alzheimer’s Drugs

A new PCR-based test accurately predicts Alzheimer’s patients’ genetic predisposition to side effects from anti-amyloid drugs.

Clinical Lab Products